AAM
LLY icon

Ascension Asset Management’s Eli Lilly LLY Stock Holding History

Ascension Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$2.84M Sell
3,140
-50
-2% -$40K 1.49% 17
2024
Q1 		$2.48M Buy
+3,190
New +$2.27M 1.34% 23
2023
Q2 		$1.48M Buy
+3,150
New +$1.32M 0.9% 42

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ascension Asset Management's LLY Position: Q2 2024 in Review

Ascension Asset Management reduced its Eli Lilly (LLY) stake by 1.6% in Q2 2024, selling an estimated $40K and leaving 3,140 shares worth $2.84M. The position accounts for 1.49% of the portfolio, ranked #17.

Ascension Asset Management first reported a position in LLY in Q2 2023 and has held it in 3 quarters since. 3,564 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

  • Ascension Asset Management held 3,140 shares of Eli Lilly worth $2.84M as of Q2 2024.
  • Ascension Asset Management sold 50 Eli Lilly shares in Q2 2024, an estimated $40K.
  • Eli Lilly made up 1.49% of Ascension Asset Management's portfolio in Q2 2024, its #17 holding.
  • Ascension Asset Management first reported a position in Eli Lilly in Q2 2023 and has held it in 3 quarters since.
  • 3,564 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Ascension Asset Management's 13F filing for Q2 2024, filed 16 Aug 2024.